Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

FMmeds vs Lyfe Rx

By GLP-1 ScorecardUpdated

FMmeds
Site position #239

Higher grade

Lyfe Rx
Site position #478

Lower grade

Score comparison

FMmeds has the higher recorded score — 65.7/100 to 55.9/100.

FMmeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FMmeds is a Manhattan Beach-based DTC telehealth platform selling compounded semaglutide and tirzepatide co-formulated with vitamin B12, with no membership fee and a free initial visit billed only on approval.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueLyfe Rx +4
46
50
Dose & formulationFMmeds +8
72
64
Clinical oversightFMmeds +27
82
55
Labs & monitoringFMmeds +1
53
52
FulfillmentFMmeds +35
97
62
Contract termsLyfe Rx +8
47
55
FMmeds · top barLyfe Rx · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricFMmedsLyfe Rx
WeighScore65.7/10055.9/100
GradeCC
Site position#239#478
Semaglutide$225/mo (all doses, compounded)$225/mo (compounded)
Tirzepatide$265/mo (all doses, compounded)$299/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
FMmeds

Site position #239 · C

Strengths

  • All 50 states plus DC covered, stated in the Terms
  • Operating LLC and full Manhattan Beach, CA address disclosed
  • Named 503A pharmacy partner (Manifest Pharmacy, Greer SC)
  • Aggressive 12-month pricing — semaglutide $95/mo and tirzepatide $145/mo, at the low end of the market
  • Flat pricing across all dose strengths — no dose-escalation surcharge

What to consider

  • Compounded only — no FDA-approved Wegovy, Ozempic, Mounjaro, or Zepbound
  • Publishes the FDA compounded-medication disclaimer (medication is not FDA-approved)
  • Clinical network not separately named
  • LegitScript Certified, but the specific ID isn't shown
Lyfe Rx

Site position #478 · C

FDAWarning letter issued to Lyfe Rx in September 2025. See the FDA warning-letter database.

Strengths

  • Both compounded semaglutide and tirzepatide available
  • Delivery to all 50 states with 1–3 day pharmacy turnaround

What to consider

  • No visible LegitScript or PCAB accreditation
  • Also sells non-prescription supplements ('Tirzepatide Weight Loss Supplement', 'Lipo Burn')
  • Shopify-based e-commerce storefront — less clinical infrastructure
  • FDA issued Lyfe Rx a warning letter in September 2025; the letter is public in FDA's warning-letter database

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard